Valuation: Stille AB

Market Cap 2.28B 236M 207M 190M 176M 335M 22.4B 340M 888M 11.05B 886M 867M 38.21B P/E 2026 *
25.5x
P/E 2027 * 21.2x
Enterprise Value 2.19B 227M 199M 183M 170M 322M 21.54B 327M 853M 10.63B 852M 834M 36.74B EV / Sales 2026 *
3.09x
EV / Sales 2027 * 2.68x
Free-Float
53.19%
Yield 2026 *
-
Yield 2027 * 0.79%
Manager TitleAgeSince
Chief Executive Officer 48 12/05/2025
Director of Finance/CFO 54 08/12/2025
Chief Operating Officer - 02/01/2026
Director TitleAgeSince
Director/Board Member 66 01/01/2000
Director/Board Member 63 01/01/2021
Director/Board Member 62 01/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
-3.75%-8.33% - - 236M
-1.91%+6.58%-33.29%-50.99% 13.99B
-0.85%+13.57%+78.16%+114.13% 4.35B
+1.95%+0.59%+325.62%+214.59% 3.48B
-2.64%-1.23%-30.27%-31.93% 2.4B
-2.76%+3.05%-30.10%-27.92% 1.85B
+1.54%+4.10%-45.00%-68.33% 1.87B
-0.75%-2.92%-3.62%-21.76% 1.32B
-2.38%-4.09%+20.59%+29.13% 964M
-0.58%+0.12%-23.43%-21.74% 915M
Average -1.21%+2.77%+28.74%+15.02% 3.46B
Weighted average by Cap. -1.18%+6.39%+25.34%+8.13%

Financials

2026 *2027 *
Net sales 710M 73.38M 64.22M 59.18M 54.86M 104M 6.96B 106M 276M 3.44B 276M 270M 11.88B 781M 80.77M 70.68M 65.14M 60.38M 115M 7.67B 116M 304M 3.78B 303M 297M 13.08B
Net income 94.55M 9.78M 8.56M 7.89M 7.31M 13.87M 928M 14.1M 36.77M 458M 36.71M 35.91M 1.58B 108M 11.12M 9.73M 8.97M 8.31M 15.78M 1.06B 16.04M 41.83M 521M 41.76M 40.85M 1.8B
Net Debt -87.73M -9.07M -7.94M -7.32M -6.78M -12.87M -861M -13.08M -34.12M -425M -34.06M -33.32M -1.47B -187M -19.34M -16.92M -15.59M -14.45M -27.44M -1.84B -27.88M -72.72M -906M -72.59M -71.02M -3.13B
Logo Stille AB
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-